Barclays Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) but lowers the price target from $40 to $34.
October 12, 2023 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays maintains an Overweight rating on Keurig Dr Pepper but lowers the price target from $40 to $34.
The news of Barclays lowering the price target for Keurig Dr Pepper from $40 to $34, despite maintaining an Overweight rating, could potentially lead to a negative sentiment among investors. This might result in a short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100